Septilin a proprietary
herbal preparation has been reported to have wound healing and immunomodulatory properties. The present study was, therefore, designed to ascertain the anti-inflammatory and
analgesic properties of
septilin in rats and mice by oral route. Anti-inflammatory activity was assessed by using acute (
carrageenan-induced paw oedema), sub-acute (cotton pellet
granuloma) and chronic (
Freund's adjuvant induced-
arthritis) models of
inflammation. Administration of
septilin in a dose of 500 mg/kg orally produced significant anti-inflammatory effect in all experimental models of
inflammation. However, the anti-inflammatory effect was more in chronic model when compared to reference standard
drug (
Prednisolone).
Septilin (500 mg/kg) produced significant
analgesic effect on tall flick test. However, the effect was less when compared to
morphine (5 mg/kg) but when
septilin was combined with subanalgesic dose of
morphine (2.5 mg/kg) the
analgesic effect was more than the either
drug given alone. On GAA induced writhing test
septilin produced significant
analgesic effect at a dose of 750 mg/kg which was comparable to
diclofenac (50 mg/kg). However, subanalgesic dose of
septilin (500 mg/kg) when combined with
diclofenac (25 mg/kg),
analgesic effect was enhanced significantly.